IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,070,939 | +369.5% | 184,187 | +132.0% | 0.05% | +420.0% |
| Q2 2023 | $1,505,997 | -36.9% | 79,388 | -48.4% | 0.01% | -33.3% |
| Q1 2023 | $2,385,726 | +57.3% | 153,819 | +80.0% | 0.02% | +66.7% |
| Q4 2022 | $1,516,525 | +689.9% | 85,438 | +148.1% | 0.01% | +800.0% |
| Q3 2022 | $192,000 | +74.5% | 34,431 | +22.2% | 0.00% | 0.0% |
| Q2 2022 | $110,000 | -50.0% | 28,167 | -29.5% | 0.00% | -50.0% |
| Q1 2022 | $220,000 | -62.0% | 39,932 | -41.2% | 0.00% | -66.7% |
| Q4 2021 | $579,000 | -46.1% | 67,944 | -45.0% | 0.01% | -57.1% |
| Q3 2021 | $1,074,000 | +95.6% | 123,602 | +138.0% | 0.01% | +133.3% |
| Q2 2021 | $549,000 | -74.2% | 51,933 | -60.9% | 0.01% | -77.8% |
| Q1 2021 | $2,129,000 | +327.5% | 132,741 | +1132.2% | 0.03% | +285.7% |
| Q4 2020 | $498,000 | -42.8% | 10,773 | -56.4% | 0.01% | -46.2% |
| Q3 2020 | $870,000 | +698.2% | 24,729 | +450.9% | 0.01% | +550.0% |
| Q2 2020 | $109,000 | +2080.0% | 4,489 | +1224.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |